Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Miguel Reyes-Parada

66PUBLICATIONS
144CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsBiomolecular modelling and designBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

Sort by Publication Date:
|Mar 16, 2026
Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases.

Enrique Madruga, Alfonso Garcia-Rubia, Carlos Sanchez-Nuñez

|Feb 23, 2026
Identification of Potential Multitarget Directed Ligands for Alzheimer's Disease by Coupling Virtual Screening and Experimental Validation.

Paulina Valenzuela-Hormazábal, Jessica Valero-Rojas, Loreto Martínez-González

|Feb 12, 2026
Design, Synthesis, and Evaluation of Naphthyl Pyrazino-Pyrido-Pyrimidinones Targeting the Phosphoinositide 3-Kinase/Alpha-Serine/Protein Kinase B/Mammalian Target of Rapamycin Pathway.

Marcelo F Marchiori, Gabriel da Silva, Daniel F Kawano

|Aug 29, 2025
Discovery of a brain penetrant SGK1 inhibitor using a ligand- and structure-based virtual screening methodology.

Enrique Madruga, Cecilia Sanchez-Santos, Ignacio Valenzuela-Martínez

|Aug 06, 2025
Design, Synthesis and Biological Evaluation of Chromeno[3,4-<i>b</i>]xanthones as Multifunctional Agents for Alzheimer's Disease.

Daniela Malafaia, Natércia F Brás, Anna Sampietro

|May 17, 2025
From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability.

Marcos Morales-Tenorio, Fátima Lasala, Alfonso Garcia-Rubia

Pageof 11

Frequent Collaborators

26 joint publications

Carmen Gil

10 joint publications

Nuria Eugenia Campillo

7 joint publications

Valle Palomo

6 joint publications

Enrique Madruga

6 joint publications

Víctor Sebastián-Pérez

6 joint publications

Patricia Boya

6 joint publications

Ángeles Martin-Requero

6 joint publications

Inés Maestro

5 joint publications

Vanesa Nozal

5 joint publications

David Ramírez

Frequent Collaborators

26 joint publications

Carmen Gil

10 joint publications

Nuria Eugenia Campillo

7 joint publications

Valle Palomo

6 joint publications

Enrique Madruga

Top Related Videos

<em>Saccharomyces cerevisiae</em> Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

<em>Saccharomyces cerevisiae</em> Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase

Published on : Jun 24, 2025

675
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.7K
See more related videos

Top Related Videos

<em>Saccharomyces cerevisiae</em> Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

<em>Saccharomyces cerevisiae</em> Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase

Published on : Jun 24, 2025

675
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.7K
See more related videos